Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel Pd-catalyzed C-H bifunctionalization for nitrogen heterocycles. Enhances purity and supply chain reliability for pharma intermediates.
Patent CN113831366A discloses novel cinchona alkaloid ligands for high-efficiency asymmetric catalysis, offering superior stereoselectivity and scalable manufacturing for pharmaceutical intermediates.
Patent CN103193830A reveals a flexible route for chiral ferrocene phosphine ligands, offering cost reduction in pharmaceutical intermediate manufacturing and reliable supply.
Novel BF3-catalyzed route offers high yields and metal-free purification for scalable API intermediate production.
Patent CN113956208A reveals a metal-free, Eosin Y-catalyzed arylation method offering cost reduction in pharmaceutical intermediate manufacturing and scalable green chemistry solutions.
Novel C7-position stereospecific method enhances purity and supply chain reliability for pharmaceutical intermediates manufacturing globally using cost effective ruthenium catalysis.
Efficient ruthenium-catalyzed method reduces costs and environmental load for high-purity pharmaceutical intermediates manufacturing supply chain.
Patent CN111187292B details a heterogeneous cobalt-catalyzed hydrosilylation method offering high regioselectivity for alpha-vinyl silanes, ensuring cost-effective supply chain solutions.
Patent CN111320644A reveals a mild n-butyllithium catalyzed hydroboration method. This breakthrough offers significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN103435635B reveals improved TMPMgClLiCl synthesis. Enhances yield and supply chain stability for pharmaceutical intermediate manufacturing globally.
Patent CN108117507B details a green visible-light method for azaspirocyclohexadienone synthesis, offering cost reduction in pharmaceutical intermediate manufacturing and high purity.
Patent CN118307476A reveals a novel nickel-catalyzed synthesis for tetra-substituted olefins using isoprene, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN117843613A reveals high-yield synthesis for dabigatran intermediates. Offers cost reduction and supply chain reliability for pharmaceutical manufacturing partners.
Novel aqueous synthesis of diazinium derivatives using phosphotungstic acid. Offers high yield, mild conditions, and cost reduction in API manufacturing for global supply chains.
Patent CN115583635A reveals a novel LiFSI synthesis route avoiding SO2 gas. Enhances supply chain reliability and purity for battery energy storage materials.
Patent CN111041515B reveals a metal-free electrochemical route for high-purity quinoxalinone intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Novel nickel-photocatalyzed method for (R)-1,3-diarylbutene offers mild conditions and high enantioselectivity, ensuring cost-effective supply chain solutions for pharmaceutical intermediates.
Patent CN104072500A details a novel synthesis for quinoxaline imidazolium salts. This route offers significant supply chain stability and cost reduction in catalyst ligand manufacturing for global partners.
Novel silver triflate method improves yield and stability for high-purity pharmaceutical intermediates supply chain optimization.
Novel route for Dapoxetine HCl using chiral organocatalyst. High yield, >99% ee. Ideal for API intermediates and cost reduction in pharmaceutical manufacturing.